Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Heart Bypass Imaging Helps Reduce Graft Defects

By HospiMedica International staff writers
Posted on 16 Feb 2009
The technique for coronary artery bypass graft (CABG) surgery has largely remained the same over the last 35 years, including closing the chest without really knowing whether the bypass grafts are potentially kinked, constricted, or otherwise impaired.

Performing standard angiography after CABG surgery, but before the patient leaves the operating room (OR), can help identify defects and allow surgeons to correct most of them before closing, according to Vanderbilt [University] Heart and Vascular Institute (VHVI; Nashville, TN, USA) researchers.

David Zhao, M.D., and colleagues conducted a study to report their experience with routine completion angiogram after CABG and percutaneous coronary intervention (PCI). More...
Their findings will be published in the January 20, 209, issue of the Journal of the American College of Cardiology (JACC).

The study team collected data on 336 consecutive patients who underwent CABG surgery either by conventional surgical bypass or hybrid CABG and percutaneous intervention. The patients were treated in Vanderbilt's unique hybrid OR, which combines a cardiac catheterization laboratory with an operating room. Technical defects are thought to be largely responsible for graft failure rates ranging from 7-30%. "We believe that imaging our results may improve short-term and long-term graft patency,” said John Byrne, M.D., professor of cardiac surgery and chair of the department.

In the study, an interventional cardiologist or a surgeon under the supervision of a cardiologist, performed coronary graft angiography. If the angiogram identified defects, the physician made revisions either surgically or percutaneously. They repeated the angiography to ensure correction of these defects before closing the chest.

Among the 796 CABG grafts, 97 (12%) angiographic defects were identified. Defects included chest tube obstruction and kinks in vein grafts, among others. "What we have described is a very simple idea: measuring what we do. We have created an environment to give surgeons immediate feedback regarding graft quality. This could have been done many years ago, but the logistical and political barriers must have been too much at that time. Today, in the collaborative culture we have created at VHVI, this is not just possible, but routine,” Dr. Byrne said.

Except for CABG surgery, every major cardiovascular intervention is accompanied by before and after images to confirm procedural success. Vanderbilt's hybrid OR combines the tools of interventional cardiology and cardiac surgery into one procedural suite.

"Completion angiography provides immediate feedback on issues that were difficult to appreciate with the naked eye,” said Marzia Leacche, M.D., a clinical fellow in the department of cardiac surgery. "Doctors became more aware of the significance of apparently minor defects.”

The scientists believe that routine completion graft imaging should become the standard of care in CABG surgery, but it is only possible by combining the tools of surgery with the tools of interventional cardiology. A second focus of the study evaluated whether conventional CABG patients had different outcomes than patients in whom the hybrid approach was used. The mortality rate was no different between the two groups.

"At Vanderbilt, we combined the best of both worlds by doing hybrid revascularization. This study not only provides the compelling evidence that the hybrid approach is feasible and safe, but embodies the collaborative efforts from many disciplines in the Vanderbilt Heart and Vascular Institute,” concluded Dr. Zhao, associate professor of medicine and director of the Cardiac Catheterization Laboratory and Interventional Cardiology.

Related Links:
Vanderbilt Heart and Vascular Institute



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Syringes
Prefilled Saline Flush Syringes
Endoscopy Display
E190
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.